Federal contract award

75N93020C00049

TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST NO FEE
Obligations$3.8M
Current contract value$3.8M
Potential contract value / ceiling$7.2M
Start dateSep 1, 2020
Current end dateFeb 28, 2025
Potential end dateFeb 28, 2025
Latest award activityAug 5, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 5, 2026P00013$-285.5KTO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Nov 15, 2023P00012$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Mar 30, 2023P00011$538.0KTO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Jan 13, 2023P00010$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Nov 2, 2022P00009$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Aug 22, 2022P00008$704.9KTO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Jun 21, 2022P00007$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Dec 18, 2021P00006$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Oct 19, 2021P00005$0EO14042 - TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Jun 29, 2021P00004$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Apr 26, 2021P00003$0TO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Mar 3, 2021P00002$606.8KTO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Feb 3, 2021P00001$258.1KTO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.
Aug 27, 20200$2.0MTO DEVELOP AND MANUFACTURE A GMP-GRADE TMCP2 GONOCOCCAL VACCINE CANDIDATE AND ADVANCE THE CANDIDATE THROUGH A PHASE I CLINICAL TRIAL.

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.